1[1]Akhmedkhanov A, Zeleniuch J A, Toniolo P. Role of exogenous and endogenous hormones in endometrial Cancer:review of the evidence and reseach perspectives [J]. Ann NY Acad sci,2001,943:296.
2[2]Mueller M D, Vigne J L, Pritts E A, et al. Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells[J]. Fertil Steril,2003,79(2) :386 - 392.
3[3]Oehler M I Z, Wallwiener D. Wnt-7a is upreglated by morethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen - induced endometrial neoplasia[J]. Cancer Lett,2002,186(1) :75 - 81.
4[4]Rozdolski K. The effect of progestins on endometrial cancer in morphometric evaluation[J]. Ginekol Pol,2001,71(12A): 1439- 1443.
5[5]Di N L A, Jobling T, Salamonsen L A. Progestin suppresses matrix metalloproteinase production in endometrial cancer[ J ].Gynecol Oncol,2003,89(2) :325 - 333.
6[6]Wang S, Pudneg J, Song J, et al. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasis-precursor of endometrial cancer [ J ]. Gynecol Oncol,2003,88(2): 108 - 117.
7[7]Dai D, Wolf D M, Litman E S, et al. Progesterone inhibits human endometrial cancer cell growth and invasiveness: downregulation of cellular adhesion molecules through progesterone B receptors[J]. Cancer Res,2002,62(3) :881 - 886.
8[8]Elit L, Hirte H. Current status and future innovations of hormonal agents,chemotherapy and investigational agents in endometrial cancer [ J ]. Curr opin obstet Gynecol, 2002,14 ( 1 ): 67 - 73.
9[9]Montz F J, Bristow R E, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer[ J ]. Am J obstet Gynecol,2002,186(4) :651 - 657.
10[10]Imai M, Jobo T, Sato R, et al. Medroxyprogesterone acetate therapy for Patients with adenocarcinoma of the endormetrium who wish to preserve the uterus-usefulness and limitations[J].Eur J Gynaecol Oncol,2001,22(3) :217.
